 1960;2:633-6.
62. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH,
Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA
2001;286:1599-606.
63. McDermott MM, Tian L, Liu K, Guralnik JM, Ferrucci L, Tan J,
et al. Prognostic value of functional performance for mortality in
patients with peripheral artery disease. J Am Coll Cardiol 2008;51:
1482-9.
64. McDermott MM, Mehta S, Greenland P. Exertional leg symptoms
other than intermittent claudication are common in peripheral arterial
disease. Arch Intern Med 1999;159:387-92.
65. Faulkner KW, House AK, Castleden WM. The effect of cessation of
smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust 1983;1:217-9.
66. Lassila R, Lepantalo M. Cigarette smoking and the outcome after
lower limb arterial surgery. Acta Chir Scand 1988;154:635-40.
67. Willigendael EM, Teijink JA, Bartelink ML, Peters RJ, Buller HR,
Prins MH. Smoking and the patency of lower extremity bypass grafts:
a meta-analysis. J Vasc Surg 2005;42:67-74.
68. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet 1994;344:1383-9.
69. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic
Disease (LIPID) Study Group. N Engl J Med 1998;339:134